BAFNA PHARMACEUTICALS
Back to All Ratios
|
BAFNA PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 19.62 | 14.69 | 11.73 | 28.05 | 31.52 |
What is the latest Price to Cash Earnings (PCE) ratio of BAFNA PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 19.62 |
| Mar2024 | 14.69 |
| Mar2023 | 11.73 |
| Mar2022 | 28.05 |
| Mar2021 | 31.52 |
How is Price to Cash Earnings (PCE) of BAFNA PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 19.62 | 33.56 | |
| Mar2024 | 14.69 | 25.23 | |
| Mar2023 | 11.73 | -58.18 | |
| Mar2022 | 28.05 | -11.01 | |
| Mar2021 | 31.52 | - | |
Other Financial Ratios of BAFNA PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹359.2 Cr | -4% | 27.6% | 72.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,751.0 Cr | 0.2% | 7.1% | -7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,634.0 Cr | 1% | 16.8% | 12.7% | Stock Analytics | |
| CIPLA | ₹124,437.0 Cr | -2.7% | 3.5% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,871.0 Cr | 0.6% | 0.4% | 4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,333.0 Cr | -6.4% | -2.7% | -3.9% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -4% |
27.6% |
72.4% |
| SENSEX | -0.2% |
5% |
5.4% |
You may also like the below Video Courses